AstraZeneca Covid-19 Vaccine Possibly Linked To Rare Blood Clots, European Medicines Agency Says
The organization recommends rare blood clotting be listed as a very rare side effect of the vaccine.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news
More News: AstraZeneca | Coronavirus | COVID-19 | European Medicines Agency (EMA) | Pharmaceuticals | Science | Vaccines